The Re-election of Directors at 2016 Annual General Shareholders' Meeting
2016.Jun.27
OBI Pharma 's 2016 Annual General Meeting has approved to release the newly elected Director from non-competition restriction
2016.Jun.27
OBI Pharma, Inc. announces the re-appointment of Mr. Michael Chang as the Chairman of the Company.
2016.Jun.15
The company was invited to participate in the overseas NDR (Non-Deal Roadshow) organized by Credit Suisse, and reported the study results presented in the 2016 ASCO.
2016.Jun.14
OBI Pharma, Inc. will attend Cathay Securities' Conference on June 16th
2016.Jun.07
To correct the company’s Investor Conference presentation content on June 5 2016
2016.Jun.06
To clarify the media report
2016.Jun.05
The company will publish the clinical study data of the innovation research of OBI-822/OBI-821 for metastatic breast cancer patients at the annual meeting of 2016 ASCO.
2016.May.30
Announcement of the Company holding investor presentation and Significant post press conference
